DEF: byNordic Acquisition Corporation Seeks Shareholder Approval to Extend Business Combination Deadline Amid Delisting

Sentiment:

Proxy Statement


byNordic Acquisition Corporation is seeking shareholder approval to extend its business combination deadline to August 12, 2026, citing an inability to complete a merger by the original August 12, 2025 termination date and facing continued operational challenges.

Delay expectedThe primary purpose of the filing is to extend the deadline for completing a Business Combination from August 12, 2025, to August 12, 2026, explicitly detailing a delay in achieving its core objective.The company has a history of seeking and receiving multiple previous extensions, including from May 2023 to August 2023, then to February 2024 with monthly extensions until August 2024, and further extensions until August 2025.
Capital raiseThe Sponsor deposited $1,725,000 into the Trust Account in May 2023, receiving a convertible promissory note.The Sponsor provided a working capital loan of $775,000 in May 2023.The Sponsor funded a $625,000 deposit into the Trust Account in August 2023, receiving a convertible promissory note.The Sponsor funded a $710,000 convertible promissory note for working capital in August 2023 ($110,000 funded, $600,000 available).DDM Debt AB, an affiliate of the Sponsor, issued a $1,700,000 promissory note in December 2023 for general working capital.DDM provided additional loans of $300,000 in April 2024 and $200,000 in June 2024.DDM provided promissory notes of $200,000 (August 2024), $300,000 (September 2024), $300,000 (December 2024), $400,000 (January 2025), $250,000 (March 2025), and $200,000 (June 2025) for general working capital.If the Extension Amendment Proposal is approved, the Company or Sponsor will deposit the lesser of $0.04 per outstanding Public Stock share or $40,000 into the Trust Account for each monthly extension, funded by non-interest bearing, unsecured promissory notes.
Worse than expectedThe company explicitly states it 'will not be able to complete a Business Combination on or before the Original Termination Date' without the extension, indicating a failure to meet its primary objective within the initially allotted time.The delisting from Nasdaq to the OTC Pink Limited Market signifies a substantial deterioration in the company's public market standing, liquidity, and investor appeal.The necessity for repeated extensions and the ongoing reliance on non-interest bearing loans from the Sponsor/affiliates to fund operations and Trust Account deposits suggest persistent financial strain and difficulty in achieving its core mission.

Summary

  • An Annual Meeting of Stockholders will be held on August 6, 2025, at 10:00 a.m. Eastern Time, via teleconference.
  • Shareholders will vote on three proposals: (1) to amend the Certificate of Incorporation to extend the business combination deadline from August 12, 2025, to August 12, 2026 (Extension Amendment Proposal), (2) to re-elect five existing directors (Directors Proposal), and (3) to adjourn the meeting if necessary to solicit further proxies (Adjournment Proposal).
  • The company believes it will not be able to complete a Business Combination by the current August 12, 2025, deadline without the proposed extension.
  • If the Extension Amendment Proposal is approved, the Sponsor or its affiliates will deposit the lesser of $0.04 for each outstanding Public Stock share or $40,000 into the Trust Account for each monthly extension, funded by non-interest bearing, unsecured promissory notes.
  • As of July 11, 2025, the Trust Account held approximately $12,349,877, resulting in an estimated redemption price of approximately $12.25 per Public Stock share.
  • The closing price of the Public Stock on July 18, 2025, was approximately $12.12 per share, meaning exercising redemption rights would yield approximately $0.13 more per share than selling in the open market.
  • The Sponsor and certain officers and directors, who collectively own approximately 72.5% of the issued and outstanding Common Stock, intend to vote in favor of all proposals, making their approval highly likely.
  • If the Extension Amendment Proposal is not approved and a Business Combination is not completed by the original deadline, the company will liquidate, redeeming Public Stock and rendering warrants worthless.

Sentiment

Score: 3

Explanation: The company is in a precarious position, having failed to complete its primary objective and being delisted from Nasdaq. While the extension offers a chance to find a business combination, the repeated delays, reliance on sponsor funding, and significant risks (CFIUS, excise tax, illiquidity) indicate a challenging outlook. The sentiment is negative due to the underlying operational failures and market challenges, despite the board's efforts to extend the company's life.

Positives

  • The Board unanimously recommends voting FOR all proposals, indicating a unified management and board perspective.
  • The Sponsor and its affiliates, holding approximately 72.5% of the voting power, intend to vote in favor of the proposals, making their approval highly probable and providing a path for the company to continue operations.
  • The proposed extension provides an additional 12 months for the company to identify and consummate a Business Combination, potentially preserving shareholder value that would otherwise be lost in a liquidation.
  • Public Stockholders retain redemption rights, offering a potential exit at a price of approximately $12.25 per share, which is slightly higher than the recent market closing price of $12.12 per share.

Negatives

  • The company has failed to complete a Business Combination by its original termination date and explicitly states it cannot do so without the proposed extension, indicating a significant operational setback.
  • The company was delisted from the Nasdaq Stock Market on February 18, 2025, and now trades on the OTC Pink Limited Market, which has limited trading volume and increased price volatility, negatively impacting liquidity for public stockholders.
  • There is a risk of liquidation if the extension is not approved or if a Business Combination is not consummated by the extended deadline, which would result in warrants expiring worthless.
  • The company may be subject to the 1% excise tax included in the Inflation Reduction Act of 2022 on stock repurchases/redemptions, which could reduce the cash available for a business combination.
  • The Sponsor's foreign control (Water by Nordic AB, a Swedish company) may subject a Business Combination with a U.S. target to U.S. foreign investment regulations and review by CFIUS, potentially limiting the pool of targets or imposing restrictive conditions.
  • The Sponsor's ability to satisfy its indemnification obligations is uncertain, as its only assets are believed to be company securities, posing a risk to the Trust Account funds.

Risks

  • Inability to obtain the requisite stockholder approval for the Extension Amendment Proposal, Directors Proposal, and Adjournment Proposal.
  • Inability to complete a Business Combination even if the Charter Extension is approved, leading to eventual liquidation.
  • Potential for a Business Combination with a U.S. target company to be subject to U.S. foreign investment regulations and review by CFIUS, which could block, delay, or impose conditions on the transaction.
  • Redemptions by public stockholders could leave the company with insufficient cash to consummate a Business Combination on commercially acceptable terms, or at all.
  • Volatility of the market price and liquidity of the Public Stock and other securities, making it difficult for stockholders to dispose of shares at favorable prices or at all.
  • Exposure to the 1% excise tax under the Inflation Reduction Act of 2022 on certain stock repurchases, which may decrease the value of securities and hinder the ability to consummate a business combination.
  • Delisting from Nasdaq and limited trading volume on the OTC Pink Limited Market may adversely affect institutional investor interest and the company's ability to raise capital.
  • Risk of being deemed an investment company under Section 3(a)(1)(A) of the Investment Company Act of 1940, which would severely restrict activities and could force liquidation.
  • Changes to laws or regulations, or their interpretation or application, may adversely affect the business, including the ability to negotiate and complete a Business Combination.
  • The Sponsor and its affiliates' significant voting power (approximately 72.5%) means that approval of the proposals may not require the affirmative vote of any shares of Public Stock, potentially diminishing the influence of public stockholders.
  • The Sponsor's indemnification obligations to the company for certain third-party claims are uncertain, as its only assets are believed to be company securities, potentially leaving the Trust Account vulnerable.

Future Outlook

The company anticipates holding another stockholder meeting to consider and vote upon a Business Combination if the extension is approved. If the Extension Amendment Proposal is approved and the company does not complete a Business Combination by the extended termination date of August 12, 2026, the company will dissolve and liquidate, redeeming Public Stock and rendering warrants worthless. The company does not currently anticipate seeking further extensions beyond the proposed period but may do so in the future.

Management Comments

  • The Board has determined that it is advisable and in the best interests of the Company to seek an extension of the Original Termination Date and have the Company's stockholders approve the Extension Amendment Proposal to allow for a period of additional time to consummate a Business Combination.
  • Without the Charter Extension, the Company believes that it will not be able to complete a Business Combination on or before the Original Termination Date.
  • The Company believes that it is advisable and in the best interests of the Company's stockholders that the stockholders approve the Proposals.
  • The Company cannot assure stockholders that they will be able to sell their Public Stock in the open market, even if the market price per share is lower than the redemption price stated above, as there may not be sufficient liquidity in its securities when such stockholders wish to sell their shares.
  • The Company believes that such redemption right enables its Public Stockholders to determine whether or not to sustain their investments for an additional period if the Company does not complete a Business Combination on or before the Original Termination Date.
  • Other than as described in this proxy statement, the Company does not currently anticipate seeking any further extension to consummate a Business Combination, but may do so in the future.

Industry Context

This filing is characteristic of a Special Purpose Acquisition Company (SPAC) facing challenges in completing its initial business combination within the mandated timeframe. The need for repeated extensions and the recent delisting from Nasdaq reflect broader difficulties in the SPAC market, which has experienced increased redemptions, heightened regulatory scrutiny (e.g., the 1% excise tax from the Inflation Reduction Act), and a general decline in investor appetite following a period of rapid growth. The foreign sponsorship and associated CFIUS review risk further complicate the company's ability to find and close a suitable U.S. target, distinguishing it from purely domestic SPACs.

Comparison to Industry Standards

  • Many SPACs have sought extensions to their business combination deadlines, particularly in recent years, as market conditions for de-SPAC transactions have become more challenging.
  • The 1% excise tax on stock repurchases, introduced by the Inflation Reduction Act of 2022, is a new industry-wide cost factor impacting SPAC redemptions and liquidations, adding financial pressure not present in earlier SPAC cycles.
  • Delisting from a major exchange like Nasdaq to the OTC Pink Limited Market is a significant negative deviation from industry standards for publicly traded companies, typically resulting in reduced liquidity, investor interest, and access to capital compared to peers listed on national exchanges.
  • The foreign ownership structure and the associated risk of CFIUS review for U.S. target acquisitions present a specific hurdle for this SPAC, potentially narrowing its target universe and increasing transaction complexity compared to SPACs without such foreign investment concerns.
  • The high percentage of insider ownership (72.5%) and their commitment to vote for extensions is common in SPACs, providing sponsors significant control over the SPAC's lifecycle, but it also means public shareholders have limited influence over these critical decisions.

Corporate Governance

Change TypeDescriptionEffective DateImpact Assessment
Board StructureThe board of directors currently consists of five (5) directors. Directors are elected for a three-year term or until the election and qualification of their respective successors.N/AMaintains the current board size and election cycle, providing continuity in governance.
Committee FormationThe company does not currently have a standing nominating committee but intends to form a corporate governance and nominating committee as and when required by law or Nasdaq rules.N/AIndicates a commitment to future compliance with governance standards, but currently operates without a dedicated nominating committee, with independent directors fulfilling this role.
Director Re-electionFive existing directors (Jonas Olsson, Anna Yukiko Bickenbach, Anders Norlin, Fredrik Elmberg, and Steven Wasserman) have been proposed for re-election to serve for a three-year term.Upon re-election at Annual MeetingEnsures continuity of the current board and its strategic direction, particularly regarding the pursuit of a business combination.

Related Party Transactions

  • The Sponsor (Water by Nordic AB) and its affiliates (byNordic Holdings LLC, byNordic Holdings II LLC, DDM Debt AB) have provided significant loans and deposits to the company and the Trust Account to fund extensions and working capital needs.
  • The Sponsor and its affiliates beneficially own approximately 72.5% of the company's Common Stock and intend to vote in favor of all proposals, demonstrating their control over key decisions.
  • The Sponsor and the company's officers and directors have waived their rights to liquidating distributions from the Trust Account with respect to their shares if the company fails to complete a Business Combination.
  • The company will issue non-interest bearing, unsecured promissory notes to the Sponsor or its affiliates for future monthly extension deposits into the Trust Account.
  • The Sponsor has agreed to indemnify the company against certain third-party claims that reduce Trust Account funds, though the company notes uncertainty regarding the Sponsor's ability to satisfy these obligations as its only assets are believed to be company securities.

Stakeholder Impact

  • **Shareholders (Public Stockholders)**: Face potential dilution if redemptions occur, leading to a less liquid trading market and fewer stockholders. They have the option to redeem shares at a slight premium to the current market price, but liquidity for open market sales is not assured. Warrants held by public stockholders will expire worthless if the company liquidates.
  • **Sponsor and Insiders**: Have substantial financial interests tied to the completion of a Business Combination, as their significant investment and loans would be lost upon liquidation. The extension provides them with additional time to realize value from their investment.
  • **Creditors**: In the event of liquidation, the company's obligations under the Delaware General Corporation Law to provide for claims of creditors will take priority over the redemption rights of public stockholders, potentially reducing the per-share distribution amount.
  • **Management and Directors**: Their continued roles and potential for future compensation are contingent on the company's ability to complete a Business Combination, aligning their interests with the extension proposal.

Next Steps

  • Hold the Annual Meeting on August 6, 2025, to vote on the Extension Amendment Proposal, Directors Proposal, and Adjournment Proposal.
  • If the Extension Amendment Proposal is approved, file the Charter Amendment with the Delaware Secretary of State.
  • If the Extension Amendment Proposal is approved, the Company or Sponsor will deposit the required funds into the Trust Account for each monthly extension.
  • Continue efforts to consummate a Business Combination until the extended termination date of August 12, 2026.
  • If a Business Combination is consummated, repay the Convertible Promissory Notes and Non-convertible Promissory Notes from funds released from the Trust Account.
  • If a Business Combination is not completed by the extended termination date, the company will dissolve and liquidate, redeeming Public Stock and rendering warrants worthless.
  • Anticipate holding another stockholder meeting to consider and vote upon a Business Combination if the extension is approved.

Key Dates

DateDescription
2019-12-27Original Certificate of Incorporation filed with the Secretary of State of Delaware.
2020-08-28Initial S-1 Registration Statement filed with the U.S. Securities and Exchange Commission.
2022-02-03Amended and Restated Certificate of Incorporation filed with the Secretary of State of Delaware.
2022-02-11Initial Public Offering (IPO) consummated.
2022-02-18Underwriters exercised over-allotment option in full; simultaneous private sale of additional Class A Private Shares completed.
2023-05-08Board of Directors elected to extend the business combination deadline from May 11, 2023, to August 11, 2023.
2023-08-10Stockholders approved amendments to the Certificate of Incorporation, extending the Business Combination period to February 12, 2024, with monthly extensions possible until August 12, 2024.
2023-12-15Company issued a $1,700,000 promissory note to DDM Debt AB for general working capital.
2024-02-01Start of period from February 2024 to June 2024 where the Board exercised six one-month extensions of the Business Combination period.
2024-04-01Company obtained a $300,000 loan from DDM pursuant to a promissory note.
2024-06-01Company obtained a $200,000 loan from DDM pursuant to a promissory note.
2024-08-07Stockholders approved amendments to extend the business combination period from August 12, 2024, to August 12, 2025.
2024-08-01Company issued a $200,000 promissory note to DDM.
2024-09-01Company issued a $300,000 promissory note to DDM.
2024-12-01Company issued a $300,000 promissory note to DDM.
2025-01-01Company issued a $400,000 promissory note to DDM.
2025-02-18Company's securities were delisted from the Nasdaq Stock Market LLC.
2025-03-01Company issued a $250,000 promissory note to DDM.
2025-04-01Thomas Fairfield began serving as Vice President of Forttech One LLC.
2025-05-01Thomas Fairfield began serving as a member of the board of directors of M-3 Brigade Acquisition V Corp.
2025-06-01Company issued a $200,000 promissory note to DDM.
2025-06-01Michael Hermansson became Chairman of the board of Starfish of Sweden.
2025-06-30Date for beneficial ownership and Trust Account marketable securities balance.
2025-07-02Record Date for determining stockholders entitled to vote at the Annual Meeting.
2025-07-11Most recent practicable date prior to proxy statement for redemption price calculation and Trust Account balance.
2025-07-18Most recent practicable date prior to proxy statement for Public Stock closing price.
2025-07-23Proxy statement dated and first mailed to stockholders.
2025-07-30Deadline to request additional copies of documents for timely delivery (five business days before Annual Meeting).
2025-08-04Redemption Deadline (5:00 p.m. Eastern Time, two business days prior to the Annual Meeting).
2025-08-05Mail vote deadline (5:00 p.m. Eastern Time).
2025-08-06Annual Meeting date.
2025-08-12Original Termination Date for completing a Business Combination.
2026-08-12Proposed Charter Extension Date (new termination date for Business Combination).

Recommendation

sell

The company is a SPAC that has failed to complete its primary objective within the original timeframe, necessitating multiple extensions and resulting in a delisting from Nasdaq to the less liquid OTC Pink market. These factors indicate significant operational challenges and a high degree of uncertainty regarding its ability to successfully consummate a business combination. While the redemption option offers a slight premium to the current market price, the overall trajectory, the substantial control held by the Sponsor (which can push through extensions regardless of public shareholder sentiment), and the risk of warrants expiring worthless upon eventual liquidation make this a high-risk investment. A seasoned investor would likely recommend exiting the position, either through redemption if the extension is approved or by selling on the open market, to mitigate further potential losses given the company's distressed state and prolonged inability to execute its core strategy.

Keywords

SPAC, Special Purpose Acquisition Company, Business Combination, Extension, Proxy Statement, Shareholder Meeting, Redemption Rights, Nasdaq Delisting, OTC Pink, CFIUS, Inflation Reduction Act, Excise Tax, Corporate Governance, Director Re-election, Liquidation, Trust Account

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.